DECICCO CARL 4
4 · Foghorn Therapeutics Inc. · Filed Feb 1, 2021
Insider Transaction Report
Form 4
DECICCO CARL
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-28+100,000→ 100,000 totalExercise: $16.63Exp: 2031-01-27→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The options will vest as to 25% of the underlying shares of common stock on January 28, 2022, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.